Saving future lives
Ependymoma is a rare type of brain cancer, mostly seen in children. The average age at diagnosis is 5 years. Approximately 200 to 300 cases are diagnosed annually in the United States. Nobody knows the cause of these tumors.
Ependymomas develop from cells lining the ventricles, located deep within the brain. These ventricles are normally filled with cerebrospinal fluid (CSF), and help cushion the brain from trauma.
Signs & symptoms
Ependymomas can arise in both the cerebral hemispheres — the large part of the brain — and in the cerebellum.
In the cerebral hemispheres, they can cause seizures, or loss of function leading to weakness or numbness in parts of the body. In the cerebellum, ependymomas often interfere with the flow of CSF within the brain, causing a build-up of CSF known as hydrocephalus. Hydrocephalus is often associated with headaches, or a rapidly increasing head circumference in infants, and is often the first symptom of ependymoma.
Ependymoma is a serious condition that needs to be treated by a team consisting of neurosurgeons, neuro-oncologists and radiation oncologists. Even with appropriate therapies, a fraction of patients cannot be cured.
As with most tumors, treatments are limited to three modalities: surgery, radiation and chemotherapy. Surgery is the most effective therapy for ependymomas, and is used whenever possible. Because of their deep location within the brain, however, it is often difficult to completely remove ependymomas without damaging vital brain structures.
Depending on the tumor's location, your child's neurosurgeon may remove as much of the tumor as possible by creating an opening in the skull in an operation called a craniotomy. If the ependymoma can't be removed due to its location, surgery may be limited to a biopsy or partial removal of the tumor.
The prognosis for children with ependymomas varies widely depending on the characteristics of the tumor and other factors, including location and percentage of tumor removed by surgery. The percentage of tumor removed by the surgeon is the most important factor in determining prognosis. Patients whose tumors can be completely removed have a much better prognosis than patients with incompletely removed ependymomas.
Although there is controversy regarding additional treatment for ependymoma, radiation therapy is often used when a tumor cannot be entirely removed. Chemotherapy is generally ineffective for ependymoma.
UCSF Benioff Children's Hospitals medical specialists have reviewed this information. It is for educational purposes only and is not intended to replace the advice of your child's doctor or other health care provider. We encourage you to discuss any questions or concerns you may have with your child's provider.
Ivosidenib in Treating Patients With Advanced Solid Tumors, Lymphoma, or Histiocytic Disorders ...
A responder is defined as a patient who achieves a best response of partial response or complete response on the study. Response rates will be calculated as the percent of evaluable patients who are responders, and confidence inte...
RecruitingMore about this study
Our research initiatives
UCSF Brain Tumor Center Clinical Trials
Awards & recognition
One of the nation's best in neurology & neurosurgery
Ranked among the nation's best in 10 specialties